LENACAPAVIR LICENSE AGREEMENTLenacapavir License Agreement • October 18th, 2024 • New York
Contract Type FiledOctober 18th, 2024 JurisdictionThis LENACAPAVIR LICENSE AGREEMENT (the “Agreement”) is made as of 24th September 2024 (the “Effective Date”) by and between Gilead Sciences Ireland UC, an Irish unlimited liability company having its principal place of business at IDA Business & Technology Park, Carigtohill,